- Home
- TEVA vs PTC Comparison
TEVA vs PTC Comparison
Compare TEVA & PTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- PTC
- Stock Information
- Founded
- TEVA 1901
- PTC 1985
- Country
- TEVA Israel
- PTC United States
- Employees
- TEVA N/A
- PTC N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- PTC Computer Software: Prepackaged Software
- Sector
- TEVA Health Care
- PTC Technology
- Exchange
- TEVA Nasdaq
- PTC Nasdaq
- Market Cap
- TEVA 20.1B
- PTC 20.2B
- IPO Year
- TEVA N/A
- PTC 1989
- Fundamental
- Price
- TEVA $16.65
- PTC $173.18
- Analyst Decision
- TEVA Strong Buy
- PTC Buy
- Analyst Count
- TEVA 8
- PTC 14
- Target Price
- TEVA $24.50
- PTC $192.64
- AVG Volume (30 Days)
- TEVA 10.6M
- PTC 882.2K
- Earning Date
- TEVA 07-30-2025
- PTC 07-30-2025
- Dividend Yield
- TEVA N/A
- PTC N/A
- EPS Growth
- TEVA N/A
- PTC 52.11
- EPS
- TEVA N/A
- PTC 3.64
- Revenue
- TEVA $16,616,000,000.00
- PTC $2,346,680,000.00
- Revenue This Year
- TEVA $5.69
- PTC $9.90
- Revenue Next Year
- TEVA N/A
- PTC $9.07
- P/E Ratio
- TEVA N/A
- PTC $47.35
- Revenue Growth
- TEVA 3.82
- PTC 4.66
- 52 Week Low
- TEVA $12.47
- PTC $133.38
- 52 Week High
- TEVA $22.80
- PTC $203.09
- Technical
- Relative Strength Index (RSI)
- TEVA 45.87
- PTC 57.62
- Support Level
- TEVA $16.42
- PTC $167.84
- Resistance Level
- TEVA $16.95
- PTC $172.94
- Average True Range (ATR)
- TEVA 0.46
- PTC 3.12
- MACD
- TEVA -0.11
- PTC -0.04
- Stochastic Oscillator
- TEVA 16.79
- PTC 83.90
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About PTC PTC Inc.
PTC offers high-end computer-assisted design (Creo) and product lifecycle management (Windchill) software as well as Internet of Things and AR industrial solutions. Founded in 1985, PTC has 28,000 customers, with revenue stemming mostly from North America and Europe.